2023 Q2 Form 10-Q Financial Statement

#000165856623000040 Filed on May 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q4
Revenue $623.4M $616.3M $761.6M
YoY Change 31.89% 77.46% 140.69%
Cost Of Revenue $131.9M $123.0M $127.5M
YoY Change 107.41% 128.69% 155.66%
Gross Profit $491.5M $493.2M $634.0M
YoY Change 20.15% 68.05% 137.85%
Gross Profit Margin 78.84% 80.03% 83.25%
Selling, General & Admin $53.40M $36.60M $76.80M
YoY Change 408.67% 17.94% 267.24%
% of Gross Profit 10.86% 7.42% 12.11%
Research & Development $4.600M $3.200M $3.600M
YoY Change 227.87% 70.58% 23.5%
% of Gross Profit 0.94% 0.65% 0.57%
Depreciation & Amortization $215.7M $188.2M $182.1M
YoY Change 162.67% 165.04% 140.04%
% of Gross Profit 43.89% 38.16% 28.72%
Operating Expenses $432.0M $380.1M $282.7M
YoY Change 127.89% 108.61% 133.05%
Operating Profit $191.4M $236.2M $351.3M
YoY Change -32.05% 43.03% 141.87%
Interest Expense $36.83M $36.78M -$99.40M
YoY Change 157.06% 179.59% 723.46%
% of Operating Profit 19.24% 15.57% -28.29%
Other Income/Expense, Net -$15.91M $17.86M $300.0K
YoY Change -67.12% -112.52% 141.94%
Pretax Income $175.5M $254.1M $239.6M
YoY Change -24.78% 1025.23% 48.52%
Income Tax $26.55M $34.25M $40.90M
% Of Pretax Income 15.13% 13.48% 17.07%
Net Earnings $73.40M $102.1M $83.10M
YoY Change -61.74% 546.25% -48.31%
Net Earnings / Revenue 11.77% 16.57% 10.91%
Basic Earnings Per Share $0.23 $0.35
Diluted Earnings Per Share $0.21 $0.31 $0.25
COMMON SHARES
Basic Shares Outstanding 559.9M shares 295.9M shares
Diluted Shares Outstanding 351.9M shares 335.8M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $18.30M $25.60M $59.50M
YoY Change -90.9% -49.43% 534.33%
Cash & Equivalents $18.28M $25.59M $59.55M
Short-Term Investments
Other Short-Term Assets $98.10M $116.8M $121.4M
YoY Change 1264.58% 1575.03% 1971.67%
Inventory
Prepaid Expenses
Receivables $167.5M $204.9M $206.3M
Other Receivables $2.100M $2.600M $1.200M
Total Short-Term Assets $426.0M $444.0M $463.8M
YoY Change 21.77% 134.38% 435.96%
LONG-TERM ASSETS
Property, Plant & Equipment $38.73M $16.29M $15.17M
YoY Change 194.15% 38.39% 35.51%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $104.1M $76.31M $74.61M
YoY Change 209.15% 179.29% 370.61%
Total Long-Term Assets $8.500B $8.279B $8.029B
YoY Change 119.41% 119.66% 115.94%
TOTAL ASSETS
Total Short-Term Assets $426.0M $444.0M $463.8M
Total Long-Term Assets $8.500B $8.279B $8.029B
Total Assets $8.926B $8.723B $8.493B
YoY Change 111.32% 120.36% 123.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $102.5M $136.2M $51.44M
YoY Change 229.32% 253.55% 428.38%
Accrued Expenses $319.5M $252.4M $288.0M
YoY Change 174.24% 225.98% 295.04%
Deferred Revenue $275.9M $266.2M $250.1M
YoY Change 355.68% 478.7% 518.53%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $722.7M $682.0M $605.6M
YoY Change 128.64% 127.54% 260.67%
LONG-TERM LIABILITIES
Long-Term Debt $2.060B $2.043B $2.141B
YoY Change 156.92% 154.98% 159.31%
Other Long-Term Liabilities $66.40M $50.96M $3.211M
YoY Change 105.28% 11.83% -86.94%
Total Long-Term Liabilities $66.40M $50.96M $3.211M
YoY Change 105.28% 11.83% -86.94%
TOTAL LIABILITIES
Total Short-Term Liabilities $722.7M $682.0M $605.6M
Total Long-Term Liabilities $66.40M $50.96M $3.211M
Total Liabilities $3.000B $2.914B $2.836B
YoY Change 139.17% 145.44% 169.13%
SHAREHOLDERS EQUITY
Retained Earnings $363.9M $323.7M $237.2M
YoY Change -765.25% -231.3% -190.43%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.309B $3.215B $2.936B
YoY Change
Total Liabilities & Shareholders Equity $8.926B $8.723B $8.493B
YoY Change 111.32% 120.36% 123.22%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q4
OPERATING ACTIVITIES
Net Income $73.40M $102.1M $83.10M
YoY Change -61.74% 546.25% -48.31%
Depreciation, Depletion And Amortization $215.7M $188.2M $182.1M
YoY Change 162.67% 165.04% 140.04%
Cash From Operating Activities $448.5M $438.2M $528.3M
YoY Change 52.04% 173.68% 174.46%
INVESTING ACTIVITIES
Capital Expenditures $399.1M $316.5M $374.0M
YoY Change -375.88% -485.0% -457.91%
Acquisitions
YoY Change
Other Investing Activities -$8.200M $24.40M $65.40M
YoY Change -5530.46% -1397.87% -30.68%
Cash From Investing Activities -$407.3M -$292.1M -$308.6M
YoY Change 181.84% 247.41% 2938.0%
FINANCING ACTIVITIES
Cash Dividend Paid $15.19M
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -48.50M -$189.9M -195.8M
YoY Change -1212600.0% 445.77% 8.83%
NET CHANGE
Cash From Operating Activities 448.5M $438.2M 528.3M
Cash From Investing Activities -407.3M -$292.1M -308.6M
Cash From Financing Activities -48.50M -$189.9M -195.8M
Net Change In Cash -7.300M -$43.78M 23.90M
YoY Change -104.85% -206.14% 892.52%
FREE CASH FLOW
Cash From Operating Activities $448.5M $438.2M $528.3M
Capital Expenditures $399.1M $316.5M $374.0M
Free Cash Flow $49.40M $121.7M $154.3M
YoY Change -88.76% -49.77% -48.04%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001658566
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-37697
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
PERMIAN RESOURCES CORPORATION
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-5381253
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
300 N. Marienfeld St.
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1000
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Midland
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
79701
CY2023Q1 dei City Area Code
CityAreaCode
432
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
695-4222
CY2023Q1 dei Security12b Title
Security12bTitle
Class A Common Stock, par value $0.0001 per share
CY2023Q1 dei Trading Symbol
TradingSymbol
PR
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
559878410 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
25593000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
59545000 usd
CY2023Q1 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
301581000 usd
CY2022Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
282846000 usd
CY2023Q1 us-gaap Derivative Assets Current
DerivativeAssetsCurrent
108293000 usd
CY2022Q4 us-gaap Derivative Assets Current
DerivativeAssetsCurrent
100797000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8528000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
20602000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
443995000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
463790000 usd
CY2023Q1 us-gaap Unproved Oil And Gas Property Successful Effort Method
UnprovedOilAndGasPropertySuccessfulEffortMethod
1433639000 usd
CY2022Q4 us-gaap Unproved Oil And Gas Property Successful Effort Method
UnprovedOilAndGasPropertySuccessfulEffortMethod
1424744000 usd
CY2023Q1 us-gaap Proved Oil And Gas Property Successful Effort Method
ProvedOilAndGasPropertySuccessfulEffortMethod
9283311000 usd
CY2022Q4 us-gaap Proved Oil And Gas Property Successful Effort Method
ProvedOilAndGasPropertySuccessfulEffortMethod
8869174000 usd
CY2023Q1 us-gaap Oil And Gas Property Successful Effort Method Accumulated Depreciation Depletion And Amortization
OilAndGasPropertySuccessfulEffortMethodAccumulatedDepreciationDepletionAndAmortization
2600676000 usd
CY2022Q4 us-gaap Oil And Gas Property Successful Effort Method Accumulated Depreciation Depletion And Amortization
OilAndGasPropertySuccessfulEffortMethodAccumulatedDepreciationDepletionAndAmortization
2419692000 usd
CY2023Q1 us-gaap Oil And Gas Property Successful Effort Method Net
OilAndGasPropertySuccessfulEffortMethodNet
8116274000 usd
CY2022Q4 us-gaap Oil And Gas Property Successful Effort Method Net
OilAndGasPropertySuccessfulEffortMethodNet
7874226000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16294000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15173000 usd
CY2023Q1 cdev Property Plantand Equipmentand Oiland Gas Property Successful Efforts Method Net
PropertyPlantandEquipmentandOilandGasPropertySuccessfulEffortsMethodNet
8132568000 usd
CY2022Q4 cdev Property Plantand Equipmentand Oiland Gas Property Successful Efforts Method Net
PropertyPlantandEquipmentandOilandGasPropertySuccessfulEffortsMethodNet
7889399000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
70289000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
64792000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
76306000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
74611000 usd
CY2023Q1 us-gaap Assets
Assets
8723158000 usd
CY2022Q4 us-gaap Assets
Assets
8492592000 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
619828000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
562156000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
34959000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
29759000 usd
CY2023Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
344000 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1998000 usd
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
26867000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
11656000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
681998000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
605569000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
2042916000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
2140798000 usd
CY2023Q1 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
46613000 usd
CY2022Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
40947000 usd
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
50414000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
4430000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
41570000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
41341000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
50961000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3211000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
2914472000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
2836296000 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1500000000 shares
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2891528000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2698465000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
323677000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
237226000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
36777000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
13154000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
3215262000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2935748000 usd
CY2023Q1 us-gaap Minority Interest
MinorityInterest
2593424000 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
2720548000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5808686000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5656296000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8723158000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8492592000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
616268000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
347277000 usd
CY2023Q1 cdev Oil And Gas Producing Activities Lease Operating Expense
OilAndGasProducingActivitiesLeaseOperatingExpense
74532000 usd
CY2022Q1 cdev Oil And Gas Producing Activities Lease Operating Expense
OilAndGasProducingActivitiesLeaseOperatingExpense
28734000 usd
CY2023Q1 us-gaap Production Tax Expense
ProductionTaxExpense
48509000 usd
CY2022Q1 us-gaap Production Tax Expense
ProductionTaxExpense
25051000 usd
CY2023Q1 cdev Oil And Gas Producing Activities Transportation Costs
OilAndGasProducingActivitiesTransportationCosts
15482000 usd
CY2022Q1 cdev Oil And Gas Producing Activities Transportation Costs
OilAndGasProducingActivitiesTransportationCosts
21891000 usd
CY2023Q1 cdev Depreciation Depletion Amortization And Asset Retirement Obligation Accretion Expense
DepreciationDepletionAmortizationAndAssetRetirementObligationAccretionExpense
188219000 usd
CY2022Q1 cdev Depreciation Depletion Amortization And Asset Retirement Obligation Accretion Expense
DepreciationDepletionAmortizationAndAssetRetirementObligationAccretionExpense
71009000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
35474000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
30603000 usd
CY2023Q1 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
13299000 usd
CY2022Q1 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
0 usd
CY2023Q1 us-gaap Impairment Of Oil And Gas Properties
ImpairmentOfOilAndGasProperties
245000 usd
CY2022Q1 us-gaap Impairment Of Oil And Gas Properties
ImpairmentOfOilAndGasProperties
2627000 usd
CY2023Q1 us-gaap Exploration Expense
ExplorationExpense
4374000 usd
CY2022Q1 us-gaap Exploration Expense
ExplorationExpense
2307000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
380134000 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
182222000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
66000 usd
CY2022Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
82000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
236200000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
165137000 usd
CY2023Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
54512000 usd
CY2022Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-129523000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
120000 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
118000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
17855000 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-142559000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
254055000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
22578000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
34254000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6776000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
219801000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
15802000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
117681000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
102120000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
15802000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.35
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2023Q1 us-gaap Profit Loss
ProfitLoss
219801000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
15802000 usd
CY2023Q1 cdev Depreciation Depletion Amortization And Asset Retirement Obligation Accretion Expense
DepreciationDepletionAmortizationAndAssetRetirementObligationAccretionExpense
188219000 usd
CY2022Q1 cdev Depreciation Depletion Amortization And Asset Retirement Obligation Accretion Expense
DepreciationDepletionAmortizationAndAssetRetirementObligationAccretionExpense
71009000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
17871000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
5545000 usd
CY2023Q1 cdev Share Based Payment Arrangement Liability Awards
ShareBasedPaymentArrangementLiabilityAwards
0 usd
CY2022Q1 cdev Share Based Payment Arrangement Liability Awards
ShareBasedPaymentArrangementLiabilityAwards
13720000 usd
CY2023Q1 us-gaap Exploration Abandonment And Impairment Expense
ExplorationAbandonmentAndImpairmentExpense
245000 usd
CY2022Q1 us-gaap Exploration Abandonment And Impairment Expense
ExplorationAbandonmentAndImpairmentExpense
2627000 usd
CY2023Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
33454000 usd
CY2022Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
6776000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Property
GainLossOnSaleOfProperty
66000 usd
CY2022Q1 us-gaap Gain Loss On Sale Of Property
GainLossOnSaleOfProperty
82000 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
14777000 usd
CY2022Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-86645000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2796000 usd
CY2022Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1492000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1503000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
53824000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1016000 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
415000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-6811000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
10825000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
438213000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
160120000 usd
CY2023Q1 us-gaap Payments To Acquire Oil And Gas Property
PaymentsToAcquireOilAndGasProperty
100755000 usd
CY2022Q1 us-gaap Payments To Acquire Oil And Gas Property
PaymentsToAcquireOilAndGasProperty
1928000 usd
CY2023Q1 us-gaap Payments To Explore And Develop Oil And Gas Properties
PaymentsToExploreAndDevelopOilAndGasProperties
315285000 usd
CY2022Q1 us-gaap Payments To Explore And Develop Oil And Gas Properties
PaymentsToExploreAndDevelopOilAndGasProperties
81156000 usd
CY2023Q1 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
1204000 usd
CY2022Q1 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
1052000 usd
CY2023Q1 us-gaap Noncash Or Part Noncash Divestiture Amount Of Consideration Received1
NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1
60000000 usd
CY2022Q1 us-gaap Noncash Or Part Noncash Divestiture Amount Of Consideration Received1
NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1
0 usd
CY2023Q1 us-gaap Proceeds From Sale Of Oil And Gas Property And Equipment
ProceedsFromSaleOfOilAndGasPropertyAndEquipment
65116000 usd
CY2022Q1 us-gaap Proceeds From Sale Of Oil And Gas Property And Equipment
ProceedsFromSaleOfOilAndGasPropertyAndEquipment
48000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-292128000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-84088000 usd
CY2023Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
160000000 usd
CY2022Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
135000000 usd
CY2023Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
260000000 usd
CY2022Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
160000000 usd
CY2023Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
CY2022Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
8530000 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
231000 usd
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
29418000 usd
CY2022Q1 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
0 usd
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
15192000 usd
CY2022Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
0 usd
CY2023Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
13324000 usd
CY2022Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
0 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
32160000 usd
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1259000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-189863000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-34788000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-43778000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
41244000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
69932000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9935000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
26154000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
51179000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
48521000 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
8903000 usd
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
800000 usd
CY2022Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
215709000 usd
CY2022Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
63483000 usd
CY2023Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
24801000 usd
CY2022Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
0 usd
CY2023Q1 us-gaap Asset Retirement Obligation Period Increase Decrease
AssetRetirementObligationPeriodIncreaseDecrease
601000 usd
CY2022Q1 us-gaap Asset Retirement Obligation Period Increase Decrease
AssetRetirementObligationPeriodIncreaseDecrease
145000 usd
CY2023Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
1535000 usd
CY2022Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
0 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
25593000 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
50624000 usd
CY2023Q1 us-gaap Restricted Cash
RestrictedCash
561000 usd
CY2022Q1 us-gaap Restricted Cash
RestrictedCash
555000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
26154000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
51179000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5656296000 usd
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
32160000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
231000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
241000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
17871000 usd
CY2023Q1 us-gaap Dividends
Dividends
15669000 usd
CY2023Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
13950000 usd
CY2023Q1 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
2750000 shares
CY2023Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
29418000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
2416000 usd
CY2023Q1 cdev Equity Impact From Changes In Common Units Net Of Tax Benefit Of30 Million
EquityImpactFromChangesInCommonUnitsNetOfTaxBenefitOf30Million
3027000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
219801000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5808686000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2750720000 usd
CY2022Q1 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
1259000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
268000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5545000 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the Company’s consolidated financial statements requires the Company’s management to make various assumptions, judgments and estimates to determine the reported amounts of assets, liabilities, revenues and expenses, and the disclosures of commitments and contingencies. Changes in these assumptions, judgments and estimates will occur as a result of the passage of time and the occurrence of future events, and accordingly, actual results could differ from amounts previously established. Additionally, the prices received for oil, natural gas and NGL production can heavily influence the Company’s assumptions, judgments and estimates and continued volatility of oil and gas prices could have a significant impact on the Company’s estimates.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The more significant areas requiring the use of assumptions, judgments and estimates include: (i) oil and natural gas reserves; (ii) cash flow estimates used in impairment tests for long-lived assets; (iii) impairment expense of unproved properties; (iv) depreciation, depletion and amortization; (v) asset retirement obligations; (vi) determining fair value and allocating purchase price in connection with business combinations and asset acquisitions; (vii) accrued revenues and related receivables; (viii) accrued liabilities; (ix) derivative valuations; (x) deferred income taxes; and (xi) determining the fair values of certain stock-based compensation awards.</span></div>
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
136189000 usd
CY2023Q1 us-gaap Asset Acquisition Consideration Transferred Transaction Cost
AssetAcquisitionConsiderationTransferredTransactionCost
1600000 usd
CY2023Q1 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
125000000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Oil And Gas Property And Equipment
ProceedsFromSaleOfOilAndGasPropertyAndEquipment
65000000 usd
CY2023Q1 us-gaap Noncash Or Part Noncash Divestiture Amount Of Consideration Received1
NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1
60000000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
51443000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
204897000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
206266000 usd
CY2023Q1 us-gaap Oil And Gas Joint Interest Billing Receivables Current
OilAndGasJointInterestBillingReceivablesCurrent
79099000 usd
CY2022Q4 us-gaap Oil And Gas Joint Interest Billing Receivables Current
OilAndGasJointInterestBillingReceivablesCurrent
58375000 usd
CY2023Q1 us-gaap Hedging Assets Current
HedgingAssetsCurrent
15018000 usd
CY2022Q4 us-gaap Hedging Assets Current
HedgingAssetsCurrent
16999000 usd
CY2023Q1 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
2567000 usd
CY2022Q4 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
1206000 usd
CY2023Q1 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
301581000 usd
CY2022Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
282846000 usd
CY2023Q1 cdev Accrued Capital Expenditures
AccruedCapitalExpenditures
123633000 usd
CY2022Q4 cdev Accrued Capital Expenditures
AccruedCapitalExpenditures
133854000 usd
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
266226000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
250120000 usd
CY2023Q1 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
14058000 usd
CY2022Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
33897000 usd
CY2023Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
33087000 usd
CY2022Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
45627000 usd
CY2023Q1 us-gaap Hedging Liabilities Current
HedgingLiabilitiesCurrent
0 usd
CY2022Q4 us-gaap Hedging Liabilities Current
HedgingLiabilitiesCurrent
2342000 usd
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
46635000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
44873000 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
619828000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
562156000 usd
CY2023Q1 us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
0 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
2042916000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
2140798000 usd
CY2023Q1 us-gaap Debt Instrument Redemption Price Percentage
DebtInstrumentRedemptionPricePercentage
1
CY2022Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
40947000 usd
CY2023Q1 us-gaap Asset Retirement Obligation Liabilities Incurred
AssetRetirementObligationLiabilitiesIncurred
601000 usd
CY2023Q1 cdev Asset Retirement Obligation Liabilities Acquired
AssetRetirementObligationLiabilitiesAcquired
5260000 usd
CY2023Q1 us-gaap Asset Retirement Obligation Liabilities Settled
AssetRetirementObligationLiabilitiesSettled
878000 usd
CY2023Q1 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
683000 usd
CY2023Q1 us-gaap Asset Retirement Obligation
AssetRetirementObligation
46613000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
17871000 usd
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
19265000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
6300000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2056467 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
15.44
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2023Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
39333 shares
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
5.88
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0 shares
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
502000 shares
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
15.17
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1515134 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
15.77
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y10M24D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
497000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1501132 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
15.92
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y10M24D
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
353000 usd
CY2023Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
54512000 usd
CY2022Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-129523000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
28100000
CY2023Q1 us-gaap Proceeds From Repurchase Of Equity
ProceedsFromRepurchaseOfEquity
-29400000 usd
CY2023Q1 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
2800000 shares
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
102120000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
15802000 usd
CY2023Q1 us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
1375000 usd
CY2022Q1 us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
1293000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
103495000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
17095000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
295913000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
284851000 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
27314000 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
27074000 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
12621000 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
7755000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
335848000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
319680000 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.35
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2023Q1 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
2800000 shares
CY2023Q1 us-gaap Proceeds From Repurchase Of Equity
ProceedsFromRepurchaseOfEquity
-29400000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
616268000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
347277000 usd
CY2023Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
204900000 usd
CY2022Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
206300000 usd

Files In Submission

Name View Source Status
cdev-20230331_cal.xml Edgar Link unprocessable
cdev-20230331_def.xml Edgar Link unprocessable
0001658566-23-000040-index-headers.html Edgar Link pending
0001658566-23-000040-index.html Edgar Link pending
0001658566-23-000040.txt Edgar Link pending
0001658566-23-000040-xbrl.zip Edgar Link pending
cdev-20230331.htm Edgar Link pending
cdev-20230331.xsd Edgar Link pending
exhibit311q1-23.htm Edgar Link pending
exhibit312q1-23.htm Edgar Link pending
exhibit313q1-23.htm Edgar Link pending
exhibit321q1-23.htm Edgar Link pending
exhibit322q1-23.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
cdev-20230331_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cdev-20230331_pre.xml Edgar Link unprocessable
cdev-20230331_htm.xml Edgar Link completed
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending